Annual Secretarial Compliance Report for the year ended March 31 2026.
MEDANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Global Health Ltd (Medanta) has filed its Annual Secretarial Compliance Report for FY 2025-26 as required under SEBI LODR Regulation 24A. The secretarial auditor M/s MAKS & Co. conducted a review of compliance with applicable SEBI regulations including LODR, ICDR, SAST, SBEB, and PIT regulations. The company has complied with all major statutory provisions during the review period. One observation was noted regarding a 6-day time gap between the date of approval and submission of audited financial results for Q4/FY ended March 31, 2025 to stock exchanges, though the company clarified submissions were made within the prescribed 60-day period. No fines or penalties were imposed. All 13 compliance checkpoints including secretarial standards, policies, website disclosures, director disqualifications, RPTs, and insider trading norms were found satisfactory. No actions were taken by SEBI or stock exchanges against the company.
This is a routine compliance filing indicating the company maintained regulatory compliance during FY 2025-26. The minor timing observation carries no penalty and is unlikely to impact the stock. Overall, this is a neutral filing showing clean governance practices.